TIBER CREEK HEALTH STRATEGIES, INC.

Lobbying for GENENTECH, INC. · Biotechnology.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 17, 2025

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Issues related to the 340b program - Public Health Service Act (P.L. 78-410); Issues related to PBM reform.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.